Horizon Therapeutics (HZNP) delivered earnings and revenue surprises of 91.30% and 25.28%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock? HZNP on StockCharts.com Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. Snapshot: HZNP. HORIZON THERAPEUTICS PLC. 48.12 0.54 (1.1349 %) StockTwits Read live tweets from the financial and investing community about the stock you're interested in. Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, HZNP Stock Summary With a market capitalization of $8,979,938,676, Horizon Therapeutics Public Ltd Co has a greater market value than 86.06% of US stocks. Price to trailing twelve month operating cash flow for HZNP is currently 29.2, higher than 88.84% of US stocks with positive operating cash flow. Find the latest Horizon Therapeutics Public Lim (HZNP) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Real-time trade and investing ideas on Horizon Pharma Inc HZNP from the largest community of traders and investors. Horizon Pharma plc shares HZNP, +4.60% soared 17% in premarket trade Thursday, after the company announced positive results in a late-stage trial of a Real-time trade and investing ideas on Bank of America Corporation BAC from the largest community of traders and investors.
HZNP Stock News - Fidelity Jun 02, 2020 HZNP: Dividend Date & History for Horizon Therapeutics Plc HZNP's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. Earnings Whisper Number for HZNP: Horizon Therapeutics Horizon Therapeutics (HZNP) reports earnings on 8/5/2020. Shares are up 16.8% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings.
Horizon Therapeutics plc (HZNP) today announced that it has been named No. 1 on the Great Place to Work® Best Workplaces in Chicago 2020 list in the small and medium category. We are proud of this top workplace award and the commitment it demonstrates, especially in the challenging environment we face today, said Irina Konstantinovsky, executive vice president, chief human resources officer Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. NYSE Updated Jun 8, 2020 11:59 PM. 174,948 Watchers. Watch Real-time trade and investing ideas on Horizon Pharma Inc HZNP from the largest community of traders and investors.
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. NYSE Updated Jun 8, 2020 11:59 PM. 174,948 Watchers. Watch Real-time trade and investing ideas on Horizon Pharma Inc HZNP from the largest community of traders and investors.